Cresco Labs, a multistate cannabis company based in Chicago, on Wednesday reported revenue of $29.9 million for the second quarter, up 253% from the same period a year ago.
Net loss for the quarter, ending June 30, was $3.9 million, compared with net income of $1.6 million for the prior-year period.
Cresco trades on the Canadian Securities Exchange under the ticker symbol CL.
More details about the quarterly results can be found here.
For analysis and in-depth looks at the investment trends and deals driving the cannabis industry forward, sign up for our premium subscription service, Investor Intelligence.